
William P. Neuder
Examiner (ID: 10341)
| Most Active Art Unit | 3672 |
| Art Unit(s) | 3672, 2899, 3625, 3642, 3506 |
| Total Applications | 4583 |
| Issued Applications | 4090 |
| Pending Applications | 166 |
| Abandoned Applications | 332 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16837989
[patent_doc_number] => 20210146001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => MEDICAL DRESSING MATERIAL HAVING CHITOSAN FABRIC SPONGE STRUCTURE AND METHOD OF MANUFACTURING SAME
[patent_app_type] => utility
[patent_app_number] => 17/048306
[patent_app_country] => US
[patent_app_date] => 2019-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048306
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048306 | MEDICAL DRESSING MATERIAL HAVING CHITOSAN FABRIC SPONGE STRUCTURE AND METHOD OF MANUFACTURING SAME | Apr 16, 2019 | Abandoned |
Array
(
[id] => 16837805
[patent_doc_number] => 20210145817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => APIXABAN FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/047428
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7349
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047428 | Apixaban formulations | Apr 14, 2019 | Issued |
Array
(
[id] => 17241832
[patent_doc_number] => 20210361575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => LIPID PRODRUGS FOR USE IN DRUG DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/046270
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -99
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046270
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046270 | LIPID PRODRUGS FOR USE IN DRUG DELIVERY | Apr 10, 2019 | Abandoned |
Array
(
[id] => 16612028
[patent_doc_number] => 20210030681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => MULTIPARTICULATE SOLID DOSAGE FORM HAVING AN ELASTIC TEXTURE
[patent_app_type] => utility
[patent_app_number] => 17/046107
[patent_app_country] => US
[patent_app_date] => 2019-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046107
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046107 | MULTIPARTICULATE SOLID DOSAGE FORM HAVING AN ELASTIC TEXTURE | Apr 9, 2019 | Abandoned |
Array
(
[id] => 14990897
[patent_doc_number] => 20190314406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => TRANSDERMAL MAGNESIUM CREAM COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/371481
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16371481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/371481 | TRANSDERMAL MAGNESIUM CREAM COMPOSITIONS | Mar 31, 2019 | Abandoned |
Array
(
[id] => 16244770
[patent_doc_number] => 10744094
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Extended release pharmaceutical formulation
[patent_app_type] => utility
[patent_app_number] => 16/367855
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 14991
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 456
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16367855
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/367855 | Extended release pharmaceutical formulation | Mar 27, 2019 | Issued |
Array
(
[id] => 16518636
[patent_doc_number] => 10869838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Extended release pharmaceutical formulation
[patent_app_type] => utility
[patent_app_number] => 16/362848
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 25
[patent_no_of_words] => 22841
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16362848
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/362848 | Extended release pharmaceutical formulation | Mar 24, 2019 | Issued |
Array
(
[id] => 19854536
[patent_doc_number] => 12257347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Pharmaceutical composition comprising meta arsenite and method of manufacture
[patent_app_type] => utility
[patent_app_number] => 16/982399
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15416
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 493
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982399
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982399 | Pharmaceutical composition comprising meta arsenite and method of manufacture | Mar 20, 2019 | Issued |
Array
(
[id] => 14563741
[patent_doc_number] => 20190209477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => Anticancer Compositions
[patent_app_type] => utility
[patent_app_number] => 16/357821
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357821
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/357821 | Anticancer compositions | Mar 18, 2019 | Issued |
Array
(
[id] => 14563741
[patent_doc_number] => 20190209477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => Anticancer Compositions
[patent_app_type] => utility
[patent_app_number] => 16/357821
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357821
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/357821 | Anticancer compositions | Mar 18, 2019 | Issued |
Array
(
[id] => 14563741
[patent_doc_number] => 20190209477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => Anticancer Compositions
[patent_app_type] => utility
[patent_app_number] => 16/357821
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357821
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/357821 | Anticancer compositions | Mar 18, 2019 | Issued |
Array
(
[id] => 14563741
[patent_doc_number] => 20190209477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => Anticancer Compositions
[patent_app_type] => utility
[patent_app_number] => 16/357821
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357821
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/357821 | Anticancer compositions | Mar 18, 2019 | Issued |
Array
(
[id] => 17241896
[patent_doc_number] => 20210361639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => SOLID COMPOSITIONS OF ACTIVES, PROCESSES FOR PREPARING SAME AND USES OF SUCH SOLID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/977435
[patent_app_country] => US
[patent_app_date] => 2019-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977435
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/977435 | SOLID COMPOSITIONS OF ACTIVES, PROCESSES FOR PREPARING SAME AND USES OF SUCH SOLID COMPOSITIONS | Mar 3, 2019 | Abandoned |
Array
(
[id] => 14498149
[patent_doc_number] => 20190192729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => System and Method for Treating a Wound
[patent_app_type] => utility
[patent_app_number] => 16/285945
[patent_app_country] => US
[patent_app_date] => 2019-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16285945
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/285945 | System and method for treating a wound | Feb 25, 2019 | Issued |
Array
(
[id] => 14464393
[patent_doc_number] => 20190183836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
[patent_app_type] => utility
[patent_app_number] => 16/281235
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16281235
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/281235 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | Feb 20, 2019 | Issued |
Array
(
[id] => 16568971
[patent_doc_number] => 20210007977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => COMPOSITIONS AND METHODS OF AMELIORATING PHARMACEUTICAL AVERSIVENESS WITH SALTS
[patent_app_type] => utility
[patent_app_number] => 16/970733
[patent_app_country] => US
[patent_app_date] => 2019-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970733 | COMPOSITIONS AND METHODS OF AMELIORATING PHARMACEUTICAL AVERSIVENESS WITH SALTS | Feb 17, 2019 | Abandoned |
Array
(
[id] => 16452507
[patent_doc_number] => 20200361933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => PHARMACEUTICAL COMPOUND, SALTS THEREOF, FORMULATIONS THEREOF, AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/966384
[patent_app_country] => US
[patent_app_date] => 2019-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/966384 | PHARMACEUTICAL COMPOUND, SALTS THEREOF, FORMULATIONS THEREOF, AND METHODS OF MAKING AND USING SAME | Jan 31, 2019 | Abandoned |
Array
(
[id] => 18886459
[patent_doc_number] => 11865215
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Tablet compositions comprising abiraterone acetate
[patent_app_type] => utility
[patent_app_number] => 17/044698
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2933
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044698 | Tablet compositions comprising abiraterone acetate | Jan 24, 2019 | Issued |
Array
(
[id] => 18186359
[patent_doc_number] => 11576917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Pharmaceutical compositions comprising Ibrutinib
[patent_app_type] => utility
[patent_app_number] => 16/962907
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3400
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962907
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/962907 | Pharmaceutical compositions comprising Ibrutinib | Jan 10, 2019 | Issued |
Array
(
[id] => 14273937
[patent_doc_number] => 20190134253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => WOUND MANAGEMENT SYSTEM AND METHODS OF USING
[patent_app_type] => utility
[patent_app_number] => 16/236944
[patent_app_country] => US
[patent_app_date] => 2018-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16236944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/236944 | Wound management system and methods of using | Dec 30, 2018 | Issued |